USSTOCK.TODAY
Market Closed
Log in Sign up

Coherus Oncology Misses Revenue and Loss Per Share Consensus

Earnings Whispers · ·by G4L

CHRS
CHRS Coherus Oncology Inc
$0.64 -21.61%
View chart & analysis →
  1. 1Coherus reported revenue of $14.27 million, missing consensus estimates by 10.2%.
  2. 2Coherus reported a loss per share of $0.25, missing consensus estimates by 13.6%.
  3. 3Management is cutting the workforce by approximately 30% and lowering annual Loqtorzi guidance.

So what's the key point?

Coherus revenue was 10.2% lower than what experts expected. The loss per share was smaller than expected, and the company decided to reduce its workforce by 30%.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Coherus Oncology Misses Q3 Loss and Revenue Estimates Associated Press +2 · 22h agoAlTi Global Q3 Earnings and Revenue Significantly Miss Estimates Earnings Whispers · 7h agoBitGo Holdings Inc Q3 Revenue and Profitability Metrics Miss Consensus Earnings Whispers · 7h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news